ACCESSION: MSBNK-SMB_Measured-HSA033P0167008
RECORD_TITLE: Characterized; Uric acid; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'C7neg_4865': {'bp': 28677.0, 'sum': 74505.0}, 'D143neg_4825': {'bp': 21441.0, 'sum': 54123.0}, 'D170neg_4735': {'bp': 19791.0, 'sum': 52305.0}, 'D74neg_4748': {'bp': 13196.0, 'sum': 34260.0}, 'D74neg_4681': {'bp': 2735.0, 'sum': 9355.0}, 'C16neg_4805': {'bp': 2438.0, 'sum': 8186.0}, 'D117neg_4933': {'bp': 1919.0, 'sum': 6794.0}, 'D74neg_4670': {'bp': 1793.0, 'sum': 6146.0}, 'D84neg_4832': {'bp': 1682.0, 'sum': 6906.0}, 'D136neg_4628': {'bp': 1582.0, 'sum': 5941.0}}
COMMENT: RETENTION_TIME_STDEV 0.035
COMMENT: PRECURSOR_M/Z_RAW 167.022147
COMMENT: PRECURSOR_M/Z_STDEV 0.000444
COMMENT: PRECURSOR_IN_MS1 mz 167.022180; int 999.000; delta(ppm) -0.030401
COMMENT: PROPOSED_CHARGE_STATE -1; mz 168.024441; int 46.689; cor 0.952
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 189.003479; int 21.057; cor 0.745
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 17.164; C10H4N2O; [M-H]1; delta(ppm) -17.163655
COMMENT: PROPOSED_MF SevenGoldenRules 3.053; C3H9N2O4P; [M-H]1; delta(ppm) -3.053036
COMMENT: PROPOSED_MF SevenGoldenRules 6.779; C5H4N4O3; [M-H]1; delta(ppm) 6.778572
COMMENT: PROPOSED_MF MS-FINDER 4.211; C5H4N4O3; [M-H]-; delta(ppm) 6.821946
COMMENT: PROPOSED_MF MS-FINDER 3.402; C3H9N2O4P; [M-H]-; delta(ppm) -3.067595
COMMENT: PROPOSED_MF MS-FINDER 2.612; C5H12O2S2; [M-H]-; delta(ppm) 9.626388
COMMENT: PROPOSED_MF MS-FINDER 2.575; C2H8N4O3S; [M-H]-; delta(ppm) -13.361631
COMMENT: PROPOSED_MF MS-FINDER 2.305; C10H4N2O; [M-H]-; delta(ppm) -17.262871
COMMENT: PROPOSED_MF MS-FINDER 2.190; C4H8O7; [M-H]-; delta(ppm) 14.829522
COMMENT: PROPOSED_MF SIRIUS5_Sirius 31.953; C5H4N4O3; [M-H]-; delta(ppm) 6.821946
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.482; C5H12O2S2; [M-H]-; delta(ppm) 9.626388
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H4N4O3; [M-H]-; delta(ppm) 6.821946
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.122; C5H4N4O3; [M-H]-; delta(ppm) 6.821946
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.736; C3H9N2O4P; [M-H]-; delta(ppm) -3.067595
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.312; C2H5FN4O4; [M-H]-; delta(ppm) -0.019430
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.957; C4H9ClN2O3; [M-H]-; delta(ppm) -125643.006797
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.734; C2H7ClN5O2; [M-H]-; delta(ppm) -125636.861064
COMMENT: PROPOSED_MF SIRIUS6_Sirius 24.671; C7H6NO4; [M-H]-; delta(ppm) -1.216932
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.907; C5H12O2S2; [M-H]-; delta(ppm) 9.626388
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.437; CH7N5O3P; [M-H]-; delta(ppm) 4.971254
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.608; C5H4F4N2; [M-H]-; delta(ppm) -9.463984
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.839; C3H6F2N4S; [M-H]-; delta(ppm) 8.120010
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H4N4O3; [M-H]-; delta(ppm) 6.821946
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.289; LEHOTFFKMJEONL-UHFFFAOYSA-N; [M-H]-; O=C1NC2=C(N1)C(=O)NC(=O)N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.289; KLMXEVHMXUCFEP-UHFFFAOYNA-N; [M-H]-; O=C1NC2C(N1)=NC(=O)NC2=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.289; WUULEPWXSYAKLV-UHFFFAOYSA-N; [M-H]-; O=C1N=C2C(=O)NC(=O)NC2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.128; XCUFSJHXJZGVRT-UHFFFAOYSA-N; [M-H]-; C1=NC2=C(N1O)NC(=O)NC2=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.675; NWRVKNWMZUVXOH-UHFFFAOYSA-N; [M-H]-; C1=NC2=C(N1)C(=O)[NH+](C(=O)N2)[O-]
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.277; LEHOTFFKMJEONL-UHFFFAOYSA-N; [M-H]-; Uric acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.682; KLMXEVHMXUCFEP-UHFFFAOYNA-N; [M-H]-; 5,7-dihydro-1H-purine-2,6,8(9H)-trione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.645; NWRVKNWMZUVXOH-UHFFFAOYSA-N; [M-H]-; 1-oxido-3,7-dihydropurin-1-ium-2,6-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.612; WUULEPWXSYAKLV-UHFFFAOYSA-N; [M-H]-; 2,3,4,6,8,9-hexahydro-1H-purine-2,6,8-trione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.466; XCUFSJHXJZGVRT-UHFFFAOYSA-N; [M-H]-; 9-hydroxy-3H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WUULEPWXSYAKLV-UHFFFAOYSA-N; [M-H]-; 2,3,4,6,8,9-hexahydro-1H-purine-2,6,8-trione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; KLMXEVHMXUCFEP-UHFFFAOYNA-N; [M-H]-; 5,7-dihydro-1H-purine-2,6,8(9H)-trione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.936; NWRVKNWMZUVXOH-UHFFFAOYSA-N; [M-H]-; 1-oxido-3,7-dihydropurin-1-ium-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.765; LEHOTFFKMJEONL-UHFFFAOYSA-N; [M-H]-; Uric acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.765; XCUFSJHXJZGVRT-UHFFFAOYSA-N; [M-H]-; 9-hydroxy-3H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.778; LEHOTFFKMJEONL-UHFFFAOYSA-N; [M-H]-; 7,9-dihydro-3H-purine-2,6,8-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.286; WYOFOAXXUITNKN-UHFFFAOYSA-N; [M-H]-; 3-hydroxy-7H-purine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; BYVDEPONSBVYIL-UHFFFAOYSA-N; [M-H]-; 2-[(4,6-dioxo-1H-1,3,5-triazin-2-yl)oxy]acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -5.069; LEHOTFFKMJEONL; [M-H]-; Lithate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.782; INDAQGIDBUPVSF; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.257; WYOFOAXXUITNKN; [M-H]-; 3-Hydroxyxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.823; PJKPEFPGGBAAJE; [M-H]-; 1-Hydroxyxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.361; WUULEPWXSYAKLV; [M-H]-; 4,9-dihydro-3H-purine-2,6,8-trione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.216; BYVDEPONSBVYIL; [M-H]-; 2-[(4,6-dioxo-1H-1,3,5-triazin-2-yl)oxy]acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.409; KLMXEVHMXUCFEP; [M-H]-; 5,7-dihydro-1H-purine-2,6,8(9H)-trione
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.306; LEHOTFFKMJEONL; [M-H]-; Lithate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -1.696; LEHOTFFKMJEONL; [M-H]-; Urate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -51.355; INDAQGIDBUPVSF; [M-H]-; 7-Hydroxyxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.759; XCUFSJHXJZGVRT; [M-H]-; 1H-Purine-2,6-dione, 3,9-dihydro-9-hydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.224; PJKPEFPGGBAAJE; [M-H]-; 1-Hydroxyxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.828; WYOFOAXXUITNKN; [M-H]-; 3-Hydroxyxanthine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.144; KLMXEVHMXUCFEP; [M-H]-; 5,7-dihydro-1H-purine-2,6,8(9H)-trione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.644; WUULEPWXSYAKLV; [M-H]-; 2,3,4,6,8,9-hexahydro-1H-purine-2,6,8-trione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.391; BYVDEPONSBVYIL; [M-H]-; Acetonitrile, ((1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-yl)oxy)-, dihydrate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.413; LEHOTFFKMJEONL; [M-H]-; Urate
COMMENT: CONFIDENCE Level 3: Tentative candidate, Uric acid, LEHOTFFKMJEONL-UHFFFAOYSA-N; Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (4), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000289;
CH$NAME: Uric acid
CH$NAME: 7,9-dihydro-3H-purine-2,6,8-trione
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H4N4O3
CH$EXACT_MASS: 168.028340
CH$SMILES: C12=C(NC(=O)N1)NC(=O)NC2=O
CH$IUPAC: InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)
CH$LINK: CHEBI CHEBI:17775
CH$LINK: HMDB HMDB0000289
CH$LINK: INCHIKEY LEHOTFFKMJEONL-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:1175
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.290
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 167.022203
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00r7-9300000000-21c9e90e764788ebc283
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.9998104 999.0000 41.999806 3.9524 24.77 0.9643 8 f{C1N1O1}/30.31ppm,p-C4H3N3O2
  68.0259657 35.6384 68.025929 7.9969 22.44 0.9190 8 f{C2H2N3}/8.01ppm,p-C3H1N1O3
  69.0102839 469.0320 69.010245 6.0571 91.94 0.9205 10 f{C2H1N2O1}/12.28ppm,p-C3H2N2O2
  96.0210148 534.8687 96.020966 7.6858 157.83 0.9540 10 f{C3H2N3O1}/7.08ppm,p-C2H1N1O2
  97.0048995 134.6407 97.004851 7.2986 50.19 0.9118 10 f{C3H1N2O2}/5.66ppm,p-C2H2N2O1
  124.0164918 758.0125 124.016455 5.2574 228.80 0.9205 10 f{C4H2N3O2}/10.01ppm,p-C1H1N1O1
  167.0223038 106.0034 167.022266 8.6815 30.17 1.0000 9 f{C5H3N4O3}/7.43ppm,p
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  41.999810 999.00 999
  68.025966 35.64 35
  69.010284 469.03 469
  96.021015 534.87 534
  97.004900 134.64 134
  124.016492 758.01 758
  167.022304 106.00 106
//
